Skip to main content
. 2018 Mar 9;18:70. doi: 10.1186/s12877-018-0759-6

Table 2.

Characteristics of the participants of the FranSO study at baseline

Variable EMS&P (n = 33) MV (95%-CI) WPS (n = 33) MV (95%-CI) CG (n = 34) MV (95%-CI) P-value
Age [years] 77.1 (75.6 to 78.7) 78.1 (76.3 to 80.0) 76.9 (75.2 to 78.7) .571
Body mass index [kg] 26.2 (25.3 to 27.0) 26.3 (25.4 to 27.1) 26.0  (25.2 to 26.9) .941
Lean body mass [kg/m2] a 51.8 (49.9 to 53.6) 52.1 (50.3 to 54.1) 52.6 (50.5 to 54.8) .805
Total body fat [%] a 31.6 (30.2 to 32.8) 31.4 (30.0 to 32.5) 31.4 (30.1 to 32.7) .967
Gait velocity [m/s] 1.26 (1.19 to 1.33) 1.24 (1.18 to 1.30) 1.27 (1.21 to 1.33) .857
Handgrip-strength [kg] 33.8 (31.0 to 36.6) 33.3 (31.2 to 35.4) 34.4 (32.1 to 36.6) .814
Number of diseases [n] b 2.71 (2.38 to 3.05) 2.78 (2.36 to 3.16) 2.56 (2.16 to 2.96) .584
Number of medications [n] 3.31 (2.80 to 3.83) 3.49 (3.02 to 3.95) 3.40 (2.91 to 3.91) .801
LLFDI [Index]c 1.52 (1.32 to 1.71) 1.58 (1.39 to 1.76) 1.53 (1.35 to 1.70) .193
Physical activity [Index]d 4.35 (3.84 to 4.87) 4.16 (3.65 to 4.66) 4.68 (4.10 to 5.25) .371
Training volume [min/week] 36 (24 to 48) 35 (24 to 46) 40 (28 to 51) .810
Energy intake [kJ/d]e 8967 (8385 to 9590) 8670 (7823 to 9521) 9516 (8512 to 10,488) . 352
Protein intake [g/kg/d] e 1.17 (1.06 to 1.29) 1.01 (0.90 to 1.13) 1.21 (1.06 to 1.37) .066
Total cholesterol [mg/dl] 215 (199 to 231) 205 (194 to 217) 201 (182 to 220) .422
HDL-cholesterol [mg/dl] 53.3 (49.7 to 56.9) 52.3 (48.4 to 56.2) 54.0 (48.5 to 59.6) .874
LDL-Cholesterol [mg/dl] 146 (132 to 159) 137 (127 to 147) 133 (119 to 147) .320

aBIA (InBody 770, Seoul, Korea)

bclassification suggested by Schäfer [78]

cLLFDI: abbreviated version of the “Late Life Function Disability Instrument” [38]; 5-scaled: (1) indicate “no problem”, (5) specify “impossible to do”

d7-scaled (1) indicate “very low”, (7) specified “very high” [37]

e4-day dietary diary; 95% CI: 95% confidence interval